Medbox Announces Increase in Shareholder Base and Record Revenue Generated in Q3

...HOLLYWOOD Calif. Nov. 2 2012 /- Medbox Inc. (Tic...The new shareholders have come on board at an opportune time - before ...In addition the company has reported a record setting 3 rd ... We are thrilled to have so many new people join our family of shareho...

HOLLYWOOD, Calif., Nov. 2, 2012 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX) (www.medboxinc.com) announced that they have increased their shareholder base last quarter by over 30%. The announcement comes at a time of significant additions to the company's product line, as well the launch of a new division dedicated to serving the healthcare and pharmaceutical industries.

The new shareholders have come on board at an opportune time - before the company's planned move up from the Pink Sheets to the OTC Bulletin Board. As part of this process, the company is in the midst of an audit in order to comply with the fully reporting standards set forth by the SEC.

In addition, the company has reported a record setting 3rd quarter, generating over $1.3 million in revenue and its highest EBITDA margin to date.

"We are thrilled to have so many new people join our family of shareholders," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "With our lineup of exciting new products, solid revenue growth, and specialized divisions to target specific industry sectors, it is no wonder that people from all over the world are starting to invest with our company."

In the coming months Medbox will be announcing exciting dividend programs for its shareholders upon the company meeting some of its performance goals. In addition, once the JOBS act is enacted by the SEC later this year, the company will be publicly announcing its plans to incentivize new accredited investors that acquire shares directly from the company.

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

(Date:9/7/2017)... 2017 Caris Life Sciences, a leading ... promise of precision medicine, today announced results from ... its molecular profiling approach in guiding therapeutic strategies ... plus (CGP+) with Caris Molecular Intelligence ® ... molecular level, leading to more therapeutic options and ...

(Date:9/6/2017)... 2017 Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field. ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...

(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...

(Date:9/26/2017)... ... September 26, 2017 , ... Autism Learning Partners (“ALP”) announces ... Autism, A Division of Autism Learning Partners, will be the first ALP affiliate ... based Autism services in Broomfield and will continue to operate with its current ...

(Date:9/26/2017)... ... 26, 2017 , ... DETECTO has been awarded ... 2017, the new agreement allows Premier members, at their discretion, to take advantage ... is pleased to renew our agreement with Premier to be able to supply ...

(Date:9/26/2017)... ... 26, 2017 , ... “How to Live in the Millennium”: a gripping take on how ... no longer a part of everyday life and do not affect daily choices. It ... for the thoughts, words, and actions that are chosen. “How to Live in the ...